Idiopathic Pulmonary Fibrosis
It’s commonly referred to as IPF. But Idiopathic Pulmonary Fibrosis is a disease with real world consequences – far beyond the seemingly benign three letter acronym. IPF is a disease many people refer to as ‘the deadliest disease no one has ever heard of’, yet this serious health condition could lead to more deaths than ovarian cancer, lymphoma, leukemia, and kidney cancer. Join Dr. Bill Bradford, Senior Fellow at InterMune as he discusses what the medical community is doing to bring hope to those dealing with, managing of, and suffering from, IPF. And Bob William shares his personal story.
Idiopathic Pulmonary Fibrosis
IPF is The Deadliest Disease You’ve Never Heard Of
Idiopathic pulmonary fibrosis (IPF) is a devastating and ultimately fatal lung disease characterized by excessive scarring of the lungs. Unfortunately, the current prognosis for patients with this disease is they won’t survive. IPF claims nearly 40,000 lives annually – the same as breast cancer.
Given this alarming statistic, why is it that very few people know about IPF? Most likely because it is a rare, orphan disease that affects less than 200,000 Americans. However, IPF most commonly affects people older than 50, so as our population ages, the number of people with IPF will unlikely increase.
Some proportion of IPF is familial or genetic, but the majority is “idiopathic,” meaning we don’t understand its cause. But we do know the course of IPF is always progressive, unpredictable, irreversible and ultimately fatal.
Here are the facts:
- The healthy lung is an elastic structure that easily fills with air during breathing. In IPF, the diseased lung steadily fills with scar tissue and becomes very stiff. This makes it more and more difficult to breath and for the lung to do its job of getting oxygen into the body.
- For the patient, this process results in progressive shortness of breath and the inability to maintain the normal activities of daily living, such as walking.
- The median survival time from diagnosis is 2-5 years, with a 5 year survival rate of approximately 20-40 percent, which makes IPF more rapidly lethal than many malignancies, including breast, ovarian and colorectal cancers.
- IPF is often confused with COPD (chronic obstructive pulmonary disease) or emphysema
- IPF is challenging to treat because of its unpredictability. It is not possible to predict if a patient will progress slowly or rapidly, or when the rate of decline may change.
However, the good news is that understanding of IPF has increased tremendously over the past decade. Today, there is a vibrant community investing in drug discovery and disease awareness. These efforts are close to yielding medicines that will translate into effective therapies for patients that can potentially slow disease progression, which may ultimately prolong survival.
Join Dr. Bill Bradford a senior fellow at InterMune, Inc., a biotechnology firm that has 10+ years invested in IPF research, on Thursday, May 9th and May 16th at 7:00 am (ET/PT) on The Balancing Act’s “Behind the Mystery: Rare and Genetic Diseases” series, as he sheds some light on what’s being accomplished in the field of IPF that gives hope to patients and caregivers.
For additional information please visit http://www.intermune.com
The Balancing Act® Goes Behind the Mystery of IPF on Lifetime TV
FOR IMMEDIATE RELEASE
O2 Media, Inc.
The Balancing Act® Talks Green Coffee Beans, IPF on Lifetime TV
Healthy Body LLP, InterMune Take Center Stage on Upcoming Show
(Pompano Beach, FL – CISION – May 6, 2013) Popular morning show The Balancing Act® welcomes Healthy Body LLP and InterMune to the show airing on Thursday, May 9th at 7:00 a.m. (ET/PT) on Lifetime TV. Make sure to watch as Danielle and Kristy help jump start the day with animated conversation and great information to balance and empower a women’s life.
Don’t miss this line-up taking center stage on The Balancing Act:
– Behind the Mystery: Idiopathic Pulmonary Fibrosis – It’s commonly referred to as IPF. But Idiopathic Pulmonary Fibrosis is a disease with real world consequences. IPF is a disease many people refer to as ‘the deadliest disease no one has ever heard of’, yet this serious health condition could lead to more deaths than ovarian cancer, lymphoma, leukemia, and kidney cancer. Join Dr. Bill Bradford, Senior Fellow at InterMune as he discusses what the medical community is doing to bring hope to those dealing with, managing of, and suffering from, IPF. And Heather Faver shares her personal story. http://www.intermune.com.
– Learn the Benefits of Green Coffee Bean Extract with Healthy Body Inc. – A third of Americans are overweight and another third are obese. Join Dan Wienek and Adam Hagaman of Healthy Body in a “Health Matters’ segment to learn about the benefits of green coffee beans and their role in facilitating weight loss. Tru Pure Green Coffee Beans with GCA is a new supplement that has been tested and backed up by scientific research to show impressive weight loss results, naturally.
About The Balancing Act® on Lifetime Television
Now in its 5th year, The Balancing Act® continues to empower women in all aspects of their lives. The mission at The Balancing Act is simple – the show strives to help today’s modern woman balance it all by bringing them exceptional solutions to everyday problems. Entertaining, educational and trusted by women, viewers can tune in to America’s premier morning show The Balancing Act on weekday mornings at 7:00 am (ET/PT) on Lifetime television.
For additional information or to view a segment visit: http://www.thebalancingact.com
Join the Conversation!
Like us on http://www.facebook.com/The BalancingtActFans
Follow us on Twitter at: http://twitter.com/#!/balancingacttv
Watch us on YouTube at: http://www.youtube.com/thebalancingact.